• Orlando Health Expands Alabama Network

    by | Apr 13, 2026 10:54 am | Hospitals

    One of the largest health systems in the southeastern United States is growing its presence in a new hospital acquisition. Orlando Health, a not-for-profit health system with $8.1 billion of assets under management, has acquired Regional Medical Center (RMC), a regional hospital based in Anniston, Alabama. No specific terms of the merger were... Read More »

  • Olympus Cosmetic Group Expands in Louisiana  

    by | Apr 9, 2026 3:03 pm | Physician Medical Groups

    Physician Growth Partners (PGP) reported that it advised Acadia Women’s Health & Cosmetic Surgery Center on its acquisition by Olympus Cosmetic Group. The financial terms were not disclosed.  Acadia Women’s Health & Cosmetic Surgery Center is a plastic surgery practice based in Crowley, Louisiana. It provides the full scope of cosmetic... Read More »

  • Optigy Acquires StaffHealth 

    by | Apr 9, 2026 2:16 pm | Healthcare Staffing

    Optigy, based in Sarasota, Florida, announced in an April 7 press release that it acquired StaffHealth. Terms were not disclosed.  Founded in 2012, StaffHealth is a temporary healthcare staffing platform. The company is based in Virginia Beach, Virginia.   Based in Sarasota,... Read More »

  • Qualifacts Acquires MethodOne by Computalogic

    by | Apr 8, 2026 3:02 pm | eHealth, Private Equity

    Qualifacts will be acquiring MethodOne by Computalogic, according to an April 7 press release. Computalogic is a Tennessee-based company exclusively dedicated to the development, installation and support of addiction treatment management systems. MethodOne by Computalogic is a comprehensive controlled-medication dispensing solution designed for... Read More »

  • BPOC Completes Sale of CDMO Midwest Products & Engineering

    by | Apr 8, 2026 2:56 pm | Life Sciences R&D, Private Equity

    Chicago, Illinois-based private equity firm BPOC announced on April 7 that it completed the sale of Midwest Products & Engineering to Graham Partners. Founded in 1978, Midwest Products & Engineering is a contract designer, developer and manufacturer of complex electromechanical and robotic-assisted surgical systems for the... Read More »

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Year’s Biggest Billion-Dollar Deals Top $64 Billion

by | Mar 16, 2015 8:16 pm | Biotechnology, Pharmaceuticals

Already in 2015, we’ve recorded 11 billion-dollar-plus deals, for a total of $64.4 billion. Thanks to the $21 billion AbbVie (NYSE: ABBV) bid for Pharmacyclics (NASDAQ: PCYC), the biotechnology sector accounted for $27.5 billion of those big deals. Pharmaceuticals, with four billion-plus transactions, still ranks first, with combined spending of $30.45 billion.  Read More »

What U.S. Health Care Companies Are Buying Overseas

by | Mar 9, 2015 7:27 pm | Biotechnology, Pharmaceuticals

We’re hosting a webinar on March 12 called  Cross-Border M&A: Opportunities and Issues. As a run-up to it, here’s a peek at what U.S. health care companies have bought overseas in 2015, excluding the typical pharma/biotech rights and licensing deals. We’ve seen 13 acquisitions of foreign companies so far, better than the 10 recorded in the same period in 2014. In the first two months of this year, $2.3 billion has been committed to those transactions. See the chart below. Read More »

Kythera Biopharma Goes Bald

by | Mar 2, 2015 6:23 pm | Biotechnology, Pharmaceuticals

Kythera Biopharmaceuticals (NASDAQ: KYTH), a clinical stage biopharma with a penchant for novel prescription products for the aesthetic medical market, entered into separate license agreements with Actellion Pharmceuticals Ltd. and the University of Pennsylvania last month. Actelion is selling the rights to setipiprant, a clinical-stage oral antagonist to the prostaglandin D2 receptor. Under the agreement with UPenn, Kythera acquired exclusive worldwide rights to certain patents covering the use of PGD2 receptor antagonists to treat hair loss. Not a very sexy-sounding way to look sexier, but it just might work. Read More »